RIXFLUGO
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98382005
- Registration number
- 7587150
- Mark type
- Stylized text
- Filed
- 30 Jan 2024
- Published for opposition
- 01 Oct 2024
- Registered
- 03 Dec 2024
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
Owner
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
Prosecution history
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION
- 11 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Aug 2024 — EXAMINER'S AMENDMENT ENTERED
- 27 Aug 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 27 Aug 2024 — EXAMINERS AMENDMENT E-MAILED
- 27 Aug 2024 — EXAMINERS AMENDMENT -WRITTEN
- 24 Aug 2024 — ASSIGNED TO EXAMINER
- 29 May 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Jan 2024 — NEW APPLICATION ENTERED